China Nepstar (NPD) Posts Stronger Q4 EPS of 3c

China Nepstar Chain Drugstore (NYSE: NPD) reported Q4 EPS of $0.03, versus $0.02 reported last year. Revenue for the quarter came in at $104.54 million, versus $95 million reported last year.

For earnings history and earnings-related data on China Nepstar Chain Drugstore (NPD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c